Accessibility Menu
Cannabis Suisse logo

Cannabis Suisse(OTC) CSUI

Current Price$0.01
Market Cap$600.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-99%
5 Year-87%
1 Year-57%
1 Month-8%
Cannabis Suisse last closing stock price
MetricPriceDate
Last closeUSD 0.012026-07-21
Cannabis Suisse stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.59%USD 0.012026-07-13
1 month-7.61%USD 0.012026-06-18
3 month-18.27%USD 0.012026-04-22
Year to date+39.34%USD 0.012025-12-31
1 year-57.07%USD 0.022025-07-18
3 year-82.65%USD 0.052023-07-21
5 year-86.92%USD 0.072021-07-22
Since inception-99.11%USD 0.952019-05-10

Cannabis Suisse Financials at a Glance

Market Cap

$600.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

$107.57K

EPS (TTM)

$0.00

P/E Ratio

7.73

Dividend

$0.00

Beta (Volatility)

-0.01 (Low)

Price

$0.01

Volume

10,500

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Feb 28, 2023

CSUI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannabis Suisse

Cannabis Suisse helps businesses by leasing commercial properties for their operations. It previously sold health supplements and CBD oils, but now focuses on real estate. The company’s services aim to support small businesses needing flexible space.

What’s in the Toolbox? (Products and Services)

  • Commercial Property Leasing: Leasing office and retail spaces to businesses; all revenue in the three months ended August 31, 2024 and 2025 was from leasing activities.
  • Subleasing Services: Subleasing properties to third parties; previously the sole source of income.
  • Health Supplements: Sold over-the-counter wellness products; no longer active.
  • CBD Oils: Provided cannabidiol-based oils for medical use; discontinued since June 2022.
  • Retail Tobacco and PPE: Sold cigarettes, face masks, and disinfectants; not part of current operations.

Plot Twists and Pivots (Growth and Expansion)

  • Shifted from health and CBD products to real estate leasing in June 2022.
  • Entered multiple lease agreements with entities owned by the CEO in 2022-2025.
  • Used convertible promissory notes to prepay leases at a discount since 2022.
  • Terminated its only sublease in February 2025, ending all rental income.

Why This Company Is a Bit Different

Cannabis Suisse operates only in the United States and focuses on leasing properties from related parties. Its business model relies on funding and property deals with its CEO, rather than broad market competition. The company has no unique products or global distribution networks.

Five Things You Need to Know

  • Revenue was $0 in QQ1 2026, down 100% from QQ1 2025.
  • All income came from a single sublease, now terminated as of February 2025.
  • Net income was $13,907 in QQ1 2026, up from a $535,086 loss in QQ1 2025.
  • Cash at period end was $305 in QQ1 2026, down from $25,742 in QQ1 2025.
  • Company relies on advances from its CEO to fund operations.

Bottom Line

Cannabis Suisse has shifted from health products to a real estate leasing model. Its future depends on related party funding and property management, with no current operating revenue.

AI Generated • Apr 16, 2026

Industry

Real Estate Management and Development

Sector

Real Estate

CEO

Scott McAlister

Website

cannabissuisse.com

Headquarters

Jacksonville, FL 90201, US

CSUI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-6.07%

Return on Capital

-51.62%

Return on Assets

23.61%

Earnings Yield

12.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.68M

Volume

10.50K

Avg. Volume

9.07K

Financials (TTM)

Gross Profit

-$6.37K

Operating Income

-$282.99K

EBITDA

-$49.26K

Operating Cash Flow

-$58.93K

Capital Expenditure

-$9.62

Free Cash Flow

-$58.93K

Cash & ST Invst.

$75.00

Total Debt

$2.01M

Cannabis Suisse Performance Analysis

Cannabis Suisse annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-05-31USD 7,770N/A
20232023-05-31USD 10,00028.7%
20242024-05-31USD 30,000200.0%
20252025-05-31USD 22,500-25.0%
Cannabis Suisse sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-05-31-100.0%
Q12025-08-31N/A
Q22025-11-30N/A
Q32026-02-28N/A
Cannabis Suisse annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-05-31USD -0.01N/A
20232023-05-31USD -0.0147.4%
20242024-05-31USD -0.03198.8%
20252025-05-31USD -0.01-74.5%
Cannabis Suisse sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-05-31500.0%
Q12025-08-31-83.3%
Q22025-11-30N/A
Q32026-02-28N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$2.12K

-1573.6%

Gross Margin

0.00%

N/A

Market Cap

$600.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

$26.91K

-8.8%

EBITDA

-$68.33K

-246.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$75.00

+50.0%

Total Debt

$2.01M

-18.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.77M

-20.4%

Short Term Debt

$242.00K

+1.4%

Return on Assets

23.61%

N/A

Return on Invested Capital

-1.32%

N/A

Free Cash Flow

-$17.87K

-56.1%

Operating Cash Flow

-$17.87K

-56.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MSMYMC Endeavors, Inc.
$0.00+0.00%
IDCNIndocan Resources Inc.
$0.00+0.00%
NGMCNext Generation Management Corp.
$0.10+0.00%
STMHStem Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
FFord Motor Company
$14.37+0.02%
AALAmerican Airlines Group
$14.48+0.07%

Questions About CSUI

What is the current price of Cannabis Suisse?

Cannabis Suisse is trading at $0.01 per share.

What is the 52-week range for Cannabis Suisse?

Over the past 52 weeks, Cannabis Suisse has traded between $0.00 and $0.02.

How much debt does Cannabis Suisse have?

As of the most recent reporting period, Cannabis Suisse reported total debt of $2.01M.

How much cash does Cannabis Suisse have on hand?

Cannabis Suisse reported $75.00 in cash and cash equivalents in its most recent financial results.

What is Cannabis Suisse’s dividend yield?

Cannabis Suisse does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services